These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4014206)

  • 1. Antibodies to delta antigen in asymptomatic hepatitis B surface antigen-reactive blood donors in the United States and their association with other markers of hepatitis B virus.
    Nath N; Mushahwar IK; Fang CT; Berberian H; Dodd RY
    Am J Epidemiol; 1985 Aug; 122(2):218-25. PubMed ID: 4014206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accidental hepatitis-B-surface-antigen-positive inoculations. Use of e antigen to estimate infectivity.
    Werner BG; Grady GF
    Ann Intern Med; 1982 Sep; 97(3):367-9. PubMed ID: 7114632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis-associated markers in the American Red Cross volunteer blood donor population. IV. A comparison of HBV-associated serologic markers in HBsAg-positive first-time and repeat blood donors.
    Bastiaans MJ; Nath N; Dodd RY; Barker LF
    Vox Sang; 1982; 42(4):203-10. PubMed ID: 7090335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of subtypes of hepatitis B surface antigen with e antigen and its corresponding antibody.
    Nath N; Fang CT; Ledman R; Mazzur S; Dodd RY
    J Infect Dis; 1978 Aug; 138(2):252-6. PubMed ID: 681801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus DNA in chronic HBsAg carriers: correlation with HBeAg/anti-HBe status, anti-HD and liver histology.
    Stroffolini T; Sagnelli E; Rapicetta M; Felaco FM; Filippini P; Annella T; Petruzziello A; Chionne P; Sarrecchia B; Piccinino F
    Hepatogastroenterology; 1992 Feb; 39(1):62-5. PubMed ID: 1568710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Delta infection in HBsAg carriers].
    Hess G; Slusarczyk J; Hansson BG; Dienes HP; Baumann W; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1984 Dec; 22(12):692-6. PubMed ID: 6396986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A sero-epidemiological cross-sectional study of hepatitis B virus in Zimbabwe.
    Tswana S; Chetsanga C; Nyström L; Moyo S; Nzara M; Chieza L
    S Afr Med J; 1996 Jan; 86(1):72-5. PubMed ID: 8685787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delta agent and the etiology of hepatocellular carcinoma.
    Trichopoulos D; Day NE; Tzonou A; Hadziyannis S; Kaklamani E; Sparos L; Muñoz N; Hatzakis A
    Int J Cancer; 1987 Mar; 39(3):283-6. PubMed ID: 3028967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and significance of antibodies to delta antigen in hepatitis B virus infection.
    Rizzetto M; Shih JW; Gocke DJ; Purcell RH; Verme G; Gerin JL
    Lancet; 1979 Nov; 2(8150):986-90. PubMed ID: 91776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of tests for HBeAg and anti-HBe in HBsAg positive blood donors.
    Dow BC; Macvarish I; Barr A; Crawford RJ; Mitchell R
    J Clin Pathol; 1980 Nov; 33(11):1106-9. PubMed ID: 7440758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new antigenic determinant on HBsAg. Geographic and subtype distribution and association with HBeAg and anti-HBe.
    Bastiaans MJ; Nath N; Mazzur S
    Vox Sang; 1979; 37(3):129-38. PubMed ID: 91267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody to the hepatitis B virus-associated delta-agent in immune serum globulins.
    Ponzetto A; Hoofnagle JH; Seeff LB
    Gastroenterology; 1984 Dec; 87(6):1213-6. PubMed ID: 6092192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occult Hepatitis B Virus Infection in Nigerian Blood Donors and Hepatitis B Virus Transmission Risks.
    Oluyinka OO; Tong HV; Bui Tien S; Fagbami AH; Adekanle O; Ojurongbe O; Bock CT; Kremsner PG; Velavan TP
    PLoS One; 2015; 10(7):e0131912. PubMed ID: 26148052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B e antigen in volunteer and paid blood donors.
    Tabor E; Goldfield M; Black HC; Gerety RJ
    Transfusion; 1980; 20(2):192-8. PubMed ID: 6966088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis Be antigen and antibody in hepatitis B surface antigen positive blood donors.
    Barr A; Black SH; Burrell CJ; Dow B; Macvarish I
    J Clin Pathol; 1979 Feb; 32(2):132-5. PubMed ID: 108319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases].
    Takahashi A; Sekiya C; Yazaki Y; Tominaga Y; Oohara K; Ono M; Sato H; Hasebe C; Namiki M
    Hokkaido Igaku Zasshi; 1983 Jan; 58(1):30-42. PubMed ID: 6840666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An electron microscopic demonstration of immune complexes of hepatitis B e-antigen using colloid gold as a marker.
    Stannard LM; Lennon M; Hodgkiss M; Smuts H
    J Med Virol; 1982; 9(3):165-75. PubMed ID: 7097254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of hepatitis A and B in the Shanghai area: prevalence of serum markers.
    Hu MD; Schenzle D; Deinhardt F; Scheid R
    Am J Epidemiol; 1984 Sep; 120(3):404-13. PubMed ID: 6089547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HBeAg and Anti-HBe in various groups of acute hepatitis patients and carriers of HBsAg].
    Zanetti AR
    Boll Ist Sieroter Milan; 1977 Mar; 56(1):74-8. PubMed ID: 861075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [HBeAg and anti-HBe levels in HBsAg positive blood donors].
    Hasçelik G; Günalp A
    Mikrobiyol Bul; 1989 Jan; 23(1):23-9. PubMed ID: 2626096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.